Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalThe Lancet Diabetes and Endocrinology
Volume9
Issue number4
Pages (from-to)197-199
ISSN2213-8587
DOIs
Publication statusPublished - Apr 2021

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19/diagnosis
  • Comorbidity
  • Disease Progression
  • Female
  • Hospital Mortality
  • Humans
  • Hyperthyroidism/epidemiology
  • Hypothyroidism/epidemiology
  • Male
  • Middle Aged
  • Mortality
  • Patient Outcome Assessment
  • Prognosis
  • Propensity Score
  • Risk Assessment
  • Risk Factors
  • SARS-CoV-2/pathogenicity
  • Severity of Illness Index

Cite this